Leadership Team
-
Dr. Diku Mandavia
CHIEF MEDICAL OFFICER
Dr. Diku Mandavia is a prominent medical device innovator and a recognized pioneer in point-of-care ultrasound. He has held key-leadership roles across the medical technology industry, successfully driving the commercialization of groundbreaking diagnostic tools.
Dr. Mandavia served as Chief Medical Officer (CMO) at Sonosite Inc., where he was pivotal in establishing point-of-care ultrasound as a transformative imaging category; now a multi-billion dollar global market. He later then held the same role within larger FUJIFILM Healthcare after their acquisition of Sonosite. He was also CMO at Ceribell and Brainscope where he advanced the use of artificial intelligence (AI) for neuro-diagnostics at the bedside. He also served on the board of DiA Imaging, a leader in ultrasound AI, which was acquired by Philips Healthcare.
He earned his medical degree from Memorial University in Canada, completed residency training at LAC+USC Medical Center, and is a graduate of the Stanford Graduate School of Business Executive Program.
An accomplished speaker and author, Dr. Mandavia has delivered over 200 lectures and has more than 100 publications. He is also Clinical Professor of Emergency Medicine (voluntary) at the University of Southern California and attending staff physician at Los Angeles General Medical Center.
-
Dr. Alyssa Abo, MD, MBA
VP CLINICAL INNOVATION
Dr. Alyssa Abo is a pioneering physician executive with over 20 years of experience in MedTech and digital health, recognized for integrating advanced technologies to transform clinical medicine. She pushes the boundaries of innovation by leveraging her medical, technological, and business background to deliver scalable, impactful solutions that drive patient-centered care, improve outcomes, and elevate healthcare globally. Dr. Abo’s thought leadership in medical imaging, artificial intelligence, real-world data applications, and pediatric technologies has set new standards across the healthcare ecosystem. Her leadership has been instrumental in shaping industry-wide policies adopted by organizations such as the American Academy of Pediatrics and the American Institute for Ultrasound in Medicine.
-
Catherine Maresh, JD
CHIEF IP COUNSEL
Catherine Maresh excels at the intersection of innovation and business. Catherine brings decades of international and domestic legal and corporate experience including intellectual property and business strategy, collaborations, licensing, regulatory, and compliance. As a valued business partner from inception through commercialization, she has helped curate strategy and provide legal guidance across all stages of the value lifecycle on a global basis. Prior to joining DeepSight in 2022, Catherine was an IP and innovation strategist, commercialization partner, and business integrator at Immersion Corporation and Medtronic. She began her career at Haugen Law firm, a boutique IP law firm in Minneapolis. Recognized in IAM Strategy 300: The World’s Leading IP Strategists 2019 – 2023, she is a licensed attorney in California and Minnesota and a registered U.S. Patent Attorney. She received her B.S.M.E from Marquette University and JD from William Michell.
-
Dr. Janet Goldenstein, PhD
VP SOFTWARE & AI
Janet Goldenstein is a technology leader with 20+ years of experience in medical device innovation, product development, and life-cycle management of FDA-regulated products. She has contributed to groundbreaking solutions for industry leaders such as GE Healthcare and Johnson & Johnson, as well as multiple startups. Janet has built and scaled high-performing software teams, architected FDA-compliant systems, and guided products from concept to regulatory clearance. She holds a Ph.D. in Biomedical Engineering from UC Berkeley/UC San Francisco and a Management of Technology certificate from the Haas School of Business.
-
Michael Hazarian
VP ULTRASOUND